Trial
NCT01642342
Recombinant Albumin Fusion Protein sEphB4-HSA in Treating Patients With Metastatic or Recurrent Solid Tumors
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Southern California
Collaborators
National Cancer Institute (NCI); Vasgene Therapeutics, Inc; The V Foundation for Cancer Research
Condition
Unspecified Adult Solid Tumor, Protocol Specific
Intervention
laboratory biomarker analysis
Why stopped
Lack of funding
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-08-24